Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 11 results

Author Title [ Type

] Year

Filters: Author is Treanor, John J [Clear All Filters]

Journal Article

El-Kamary, S. S., Pasetti, M. F., Mendelman, P. M., Frey, S. E., Bernstein, D. I., Treanor, J. J., et al.. (2010). Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J Infect Dis, 202(11), 1649-58. presented at the 2010 Dec 01. doi:10.1086/657087

Ramani, S., Neill, F. H., Ferreira, J., Treanor, J. J., Frey, S. E., Topham, D. J., et al.. (2017). B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine. Clin Vaccine Immunol, 24(5). presented at the 2017 May. doi:10.1128/CVI.00571-16

Belshe, R. B., Newman, F. K., Frey, S. E., Couch, R. B., Treanor, J. J., Tacket, C. O., & Yan, L.. (2004). Dose-dependent neutralizing-antibody responses to vaccinia. J Infect Dis, 189(3), 493-7. presented at the 2004 Feb 01. doi:10.1086/380906

Treanor, J. J., Schiff, G. M., Couch, R. B., Cate, T. R., Brady, R. C., C Hay, M., et al.. (2006). Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults. J Infect Dis, 193(9), 1223-8. presented at the 2006 May 01. doi:10.1086/503050

Zangwill, K. M., Treanor, J. J., Campbell, J. D., Noah, D. L., & Ryea, J.. (2008). Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans. J Infect Dis, 197(4), 580-3. presented at the 2008 Feb 15. doi:10.1086/526537

Goji, N. Ali, Nolan, C., Hill, H., Wolff, M., Noah, D. L., Williams, T. B., et al.. (2008). Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant. J Infect Dis, 198(5), 635-41. presented at the 2008 Sep 01. doi:10.1086/590916

Bernstein, D. I., Atmar, R. L., G Lyon, M., Treanor, J. J., Chen, W. H., Jiang, X., et al.. (2015). Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults. J Infect Dis, 211(6), 870-8. presented at the 2015 Mar 15. doi:10.1093/infdis/jiu497

Treanor, J. J., Atmar, R. L., Frey, S. E., Gormley, R., Chen, W. H., Ferreira, J., et al.. (2014). A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults. J Infect Dis, 210(11), 1763-71. presented at the 2014 Dec 01. doi:10.1093/infdis/jiu337

Brady, R. C., Treanor, J. J., Atmar, R. L., Keitel, W. A., Edelman, R., Chen, W. H., et al.. (2009). Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults. Vaccine, 27(37), 5091-5. presented at the 2009 Aug 13. doi:10.1016/j.vaccine.2009.06.057

Keitel, W. A., Campbell, J. D., Treanor, J. J., Walter, E. B., Patel, S. M., He, F., et al.. (2008). Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial. J Infect Dis, 198(9), 1309-16. presented at the 2008 Nov 01. doi:10.1086/592172

Treanor, J. J., Campbell, J. D., Zangwill, K. M., Rowe, T., & Wolff, M.. (2006). Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med, 354(13), 1343-51. presented at the 2006 Mar 30. doi:10.1056/NEJMoa055778